Literature DB >> 16928981

A rapid transglutaminase assay for high-throughput screening applications.

Yu-Wei Wu1, Yu-Hui Tsai.   

Abstract

Transglutaminases (TGs) are widely distributed enzymes that catalyze posttranslational modification of proteins by Ca(2+)-dependent cross-linking reactions. The family members of TGs participate in many significant processes of biological functions such as tissue regeneration, cell differentiation, apoptosis, and certain pathologies. A novel technique for TG activity assay was developed in this study. It was based on the rapid capturing, fluorescence quenching, and fast separation of the unreacted fluorescent molecules from the macromolecular product with magnetic dextran-coated charcoal. As few as 3 ng of guinea pig liver transglutaminase (gpTG) could be detected by the method; activities of 96 TG samples could be measured within an hour. The K(m) of gpTG determined by this method for monodansylcadaverine (dansyl-CAD) and N, N-dimethylcasein was 14 and 5 muM, respectively. A typical competitive inhibition pattern of cystamine on dansyl-CAD for gpTG activity was also demonstrated. The application of this technique is not limited to the use of dansyl-CAD as the fluorescent substrate of TG; other small fluor-labeled TG substrates may substitute dansyl-CAD. Finally, this method is rapid, highly sensitive, and inexpensive. It is suitable not only for high-throughput screening of enzymes or enzyme inhibitors but also for enzyme kinetic analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928981     DOI: 10.1177/1087057106291585

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  8 in total

1.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

2.  Expression of soluble recombinant transglutaminase from Zea mays in Pichia pastoris.

Authors:  Hongbo Li; Lanwei Zhang; Yanhua Cui; Xue Luo; Chaohui Xue; Shumei Wang
Journal:  World J Microbiol Biotechnol       Date:  2013-01-08       Impact factor: 3.312

3.  Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.

Authors:  Brad A Palanski; Chaitan Khosla
Journal:  Biochemistry       Date:  2018-03-28       Impact factor: 3.162

4.  A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.

Authors:  Rami A Al-Horani; Elsamani I Abdelfadiel; Daniel K Afosah; Shravan Morla; Jyothi C Sistla; Bassem Mohammed; Erika J Martin; Masahiro Sakagami; Donald F Brophy; Umesh R Desai
Journal:  J Thromb Haemost       Date:  2019-09-10       Impact factor: 5.824

5.  EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation.

Authors:  Bo Li; Marc A Antonyak; Joseph E Druso; Le Cheng; Alexander Yu Nikitin; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

6.  The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis.

Authors:  Rami A Al-Horani; Daytriona Clemons; Madhusoodanan Mottamal
Journal:  Molecules       Date:  2019-06-06       Impact factor: 4.411

7.  Biotechnological applications of transglutaminases.

Authors:  Natalie M Rachel; Joelle N Pelletier
Journal:  Biomolecules       Date:  2013-10-22

8.  Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.

Authors:  Rami A Al-Horani; Rajesh Karuturi; Michael Lee; Daniel K Afosah; Umesh R Desai
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.